Role of probiotics in amelioration of immune mediated beta cell damage and improvement of glycaemic control in Type 1 diabetes mellitus

Indian Council Of Medical Research (ICMR)0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年5月29日

试验速览

暂无简介。

•(1) Patients with type 1 diabetes mellitus, aged between 5 to 18 years. (2) diagnosed with type 1 diabetes in the last six months. (3) Informed consent for the study given by parent or a legal guardian.

•Patients with any one of the following will be excluded.
•1.Chronic medical condition that could affect gut microbiota (for example, Crohnâ??s disease, cystic fibrosis, irritable bowel syndrome, etc.).
•2.Positive screening test for Celiac disease.
•3.Receiving medications or supplements that could affect gut microbiota in last 15 days (for example: broad spectrum antibiotics, pro/prebiotics, laxatives, etc.).
•4.Children having diarrhoea in last 2 weeks.

发起方

Indian Council Of Medical Research (ICMR)